ELAB - elevaiskincare.com Trailing Twelve Months Revenue Growth

Brandmark of elevaiskincare.com (ELAB)

Explosive retail interest and B2B partner loyalty are driving a positive trend for Elevai Labs Inc. (ELAB). The year-over-year dynamics of core revenue over a rolling 12-month period illustrate the current market status, where the value 0.00 captures this metric. Growth is fueled by aesthetic medicine biotechnologies in US laboratories, while strong pricing power in the premium segment guarantees demand for unique regenerative serums.

ELAB (Elevai Labs) Sales Growth YoY (TTM) history from 11/23/2025 to 11/18/2026

Elevai Labs - analytical breakdowns and key metrics (ELAB)

- stock price and consensus target price:
Analysis of all company metrics:Elevai Skincare (ELAB)
Signature product of elevaiskincare.com

This indicator calculates the percentage change in revenue over the last 12 months relative to the same period last year, allowing the investor to assess business scaling dynamics while adjusting for seasonality. For Elevai Labs Inc. (ELAB), the current sales growth rate over the trailing 12-month period year-over-year reflects the effectiveness of the expansion of exosome-based cosmetics within the professional dermatology and aesthetic medicine clinic segments.